Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06571162
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-22
Brief Title:
A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients The INCLUDE Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
INCLUDE
Brief Summary:
Patients who had an ASCVD event at an Intermountain hospital will be screened for eligibility to be randomized Subjects who meet eligibility criteria will be randomized 11 to receive targeted care of their LDL-C through a pharmacist-driven management program or not Patients may opt-out of receiving LDL-C management by the pharmacy team at any time The purpose of this program is to increase the proportion of patients who achieve guideline-based recommendations of LDL-C levels of 70 mgdL by increasing statin andor LLT adherence and LDL-C testing Data collection as part of the study will continue until the last person randomized has had 1-year of follow-up
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None